Author

M. E. Sales

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. Espanol· 2 shared A. Salem· 1 shared A. Tata· 1 shared I. Cristofaro· 1 shared J. I. Odimegwu· 1 shared M. Di Bari· 1 shared O. A. Odukoya· 1 shared Y. Sanchez· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Espanol

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HUMAN BREAST TUMOUR CELLS VIABILITY EFFECT OF AFRICAN DIOSCOREA ROTUNDATA TUBER EXTRACTS IN MCF-7 AND MDA-MB231 CELL LINES.

J. I. Odimegwu, O. A. Odukoya, A. Espanol, M. E. Sales

This study tests the cytotoxic effects of African Dioscorea rotundata tuber extracts on breast cancer cell lines and non-tumour cells, finding higher efficacy on MCF-7 cells.

bioRxiv · May 8, 2020 · PreprintCancer Biology

The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype

A. Espanol, A. Salem, M. Di Bari, I. Cristofaro, Y. Sanchez, A. Tata, M. E. Sales

The paper investigates the effect of combining paclitaxel with muscarinic agonists on triple negative breast tumors, finding that M2 receptor activation reduces cell viability and tumor progression.

bioRxiv · Nov 29, 2019Pharmacology & Toxicology